THORACIC SPINAL CORD INJURY

Clinical trials for THORACIC SPINAL CORD INJURY explained in plain language.

Never miss a new study

Get alerted when new THORACIC SPINAL CORD INJURY trials appear

Sign up with your email to follow new studies for THORACIC SPINAL CORD INJURY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New spinal injury treatment enters first human safety tests

Disease control Not yet recruiting

This is a very early safety study testing a new treatment called CRIS100 for people who have just suffered a severe spinal cord injury in their upper to mid-back. Five participants will receive a single injection of CRIS100 directly into the injury site within 72 hours of their t…

Matched conditions: THORACIC SPINAL CORD INJURY

Phase: EARLY_PHASE1 • Sponsor: Cristália Produtos Químicos Farmacêuticos Ltda. • Aim: Disease control

Last updated Mar 23, 2026 15:15 UTC

THORACIC SPINAL CORD INJURY

Get alerted when new THORACIC SPINAL CORD INJURY trials appear

New spinal injury treatment enters first human safety tests